Zura Bio Ltd. (ZURA)
4.04
-0.12
(-2.88%)
USD |
NASDAQ |
Sep 25, 16:00
4.045
0.00 (0.00%)
After-Hours: 19:59
Zura Bio Total Assets (Quarterly) : 213.40M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 213.40M |
| March 31, 2026 | 228.64M |
| December 31, 2025 | 113.95M |
| September 30, 2025 | 143.94M |
| June 30, 2025 | 157.80M |
| March 31, 2025 | 172.50M |
| December 31, 2024 | 179.53M |
| September 30, 2024 | 189.07M |
| June 30, 2024 | 189.50M |
| March 31, 2024 | 90.48M |
| December 31, 2023 | 100.84M |
| Date | Value |
|---|---|
| September 30, 2023 | 104.59M |
| June 30, 2023 | 113.33M |
| March 31, 2023 | 44.38M |
| December 31, 2022 | 141.51M |
| September 30, 2022 | 140.48M |
| June 30, 2022 | 140.03M |
| March 31, 2022 | 140.25M |
| December 31, 2021 | 140.55M |
| September 30, 2021 | 140.91M |
| June 30, 2021 | 0.1648M |
| March 31, 2021 | 0.0956M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0647M |
| Brainstorm Cell Therapeutics, Inc. | 0.788M |
| Summit Therapeutics, Inc. | 752.18M |
| Kezar Life Sciences, Inc. | 68.00M |
| Protara Therapeutics, Inc. | 176.09M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.32M |
| Shareholders Equity (Quarterly) | 197.08M |
| Current Ratio | 12.90 |